Amacathera
Transforming Therapeutics
Toronto, Canada · Founded 2016
- Headquarters
- Toronto
- Employees
- 1–10
- Founded
- 2016
- Business Model
- B2B
- Website
- amacathera.com
- Last Round
- Corporate RoundNov 2025
- Rounds
- 4
About
AmacaThera is a clinical-stage biotechnology company transforming therapeutics through its proprietary injectable hydrogel platform, which blends hyaluronic acid and methylcellulose to enable localized, sustained release of small molecules, biologics, enzymes, and cells. The platform's tunability allows fine adjustment of drug release rate, duration, and timing for each clinical application. AmacaThera's lead program, AMT-143, is a long-acting non-opioid anesthetic for post-operative pain management, developed under a $230M global licensing agreement with Pacira BioSciences.
Summary
Amacathera is a Healthcare company based in Toronto, Canada, founded in 2016. Its most recent funding was a Corporate Round round in Nov 2025. Investors include BDC Venture Capital, Lumira Ventures and Sofinnova Partners.
Tech & App Stack
1 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company